Hovilpri
Hovilpri: New FDA-approved breakthrough treatment for herpes lesions in immunocompromised adults, offering hope for those resistant to standard antiviral therapies.
![FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults]()
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults
Published on 10/10/2026
